Maltodextrin

Generic Name: Maltodextrin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: -

CAS Number: 9050-36-6

Unique Ingredient Identifier: 7CVR7L4A2D

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)

Phase 2

Completed

Conditions: Insulin Sensitivity

Interventions: Drug: Synbiotic
Drug: Maltodextrin
Drug: Sevelamer
Other: High Fat diet
Other: Low Fat diet

First Posted Date: 2014-04-28

Last Posted Date: 2021-10-15

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 20

Registration Number: NCT02124759

Locations: 🇺🇸
Audie L. Murphy VA Hospital, STVHCS, San Antonio, Texas, United States

Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis

Phase 2

Conditions: Fatigue
Multiple Sclerosis

Interventions: Drug: Methylphenidate modified release
Drug: Maltodextrin

First Posted Date: 2013-06-17

Last Posted Date: 2015-05-12

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 96

Registration Number: NCT01879202

Locations: 🇦🇹
Medical University of Vienna, Department of Neurology, Vienna, Austria

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy